AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 195 filers reported holding AXSOME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $163,629,124 | -2.9% | 2,341,238 | -0.2% | 19.69% | -17.1% |
Q2 2023 | $168,510,263 | +35.8% | 2,344,980 | +16.6% | 23.76% | +11.3% |
Q1 2023 | $124,078,387 | -20.0% | 2,011,647 | 0.0% | 21.34% | -13.3% |
Q4 2022 | $155,158,333 | +83.3% | 2,011,647 | +6.1% | 24.61% | +65.5% |
Q3 2022 | $84,628,000 | +134.4% | 1,896,647 | +101.2% | 14.88% | +80.1% |
Q2 2022 | $36,100,000 | -7.5% | 942,571 | 0.0% | 8.26% | -10.4% |
Q1 2022 | $39,013,000 | +450.5% | 942,571 | +402.4% | 9.22% | +294.9% |
Q4 2021 | $7,087,000 | +14.6% | 187,598 | 0.0% | 2.34% | +3.9% |
Q3 2021 | $6,183,000 | -70.7% | 187,598 | -40.0% | 2.25% | -74.1% |
Q2 2021 | $21,088,000 | +48.0% | 312,598 | +24.2% | 8.67% | +44.4% |
Q1 2021 | $14,245,000 | -20.6% | 251,598 | +14.3% | 6.00% | -6.4% |
Q4 2020 | $17,931,000 | +14.3% | 220,098 | 0.0% | 6.41% | -3.4% |
Q3 2020 | $15,682,000 | -11.8% | 220,098 | +1.9% | 6.64% | -16.3% |
Q2 2020 | $17,781,000 | +59.4% | 216,098 | +14.0% | 7.93% | +17.2% |
Q1 2020 | $11,154,000 | – | 189,598 | – | 6.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |